Articles tagged with Chlamydia
A multicenter NIH trial led by the University of South Florida found combination antibiotics to be effective in treating Chlamydia-induced reactive arthritis. The study showed significant improvement in patients treated with combination antibiotics, with 22% experiencing complete remission and no adverse side effects.
UK researchers found that many urologists fail to diagnose and treat Chlamydia in young men, despite clear guidelines. In a survey of five teaching hospitals, only 7% of cases were tested for Chlamydia, and most received inadequate treatment.
Research reveals human Chlamydia pneumoniae originated from an animal source, specifically amphibians like frogs, and has adapted to infect humans. The study's findings emphasize the need for improved diagnostic tests, precautions, and vaccine development to combat this respiratory disease.
A long-term study by Indiana University School of Medicine found that frequent testing and treatment does not reduce the prevalence of chlamydia in urban teenage girls. Despite regular screenings, 84% of repeated infections were reinfections.
A study from the Sahlgrenska Academy found that teenage boys in Sweden are less likely to take responsibility for preventing the spread of chlamydia and other STIs. Researchers say that new methods are needed to reach boys with information on protection against infections.
A new urine test can diagnose Chlamydia in men within an hour, reducing the risk of transmission and complications. The test is more accurate than existing methods and has received regulatory approval.
Syphilis is experiencing a resurgence in cases, while gonorrhea has become increasingly resistant to treatment, posing significant challenges for public health efforts. New and potentially serious(STDs) like Mycoplasma genitalium have also been identified as emerging threats.
Researchers identified a new strain of Chlamydia that spread rapidly across Sweden due to an evolutionary 'hiccup' in its genetic code, allowing it to evade most established diagnostic tests. The study provides valuable insights into the evolution of the bacterium and highlights the need for updated diagnostic tools.
Researchers found that 62% of patients with chronic uSpA had Chlamydia infection, significantly higher than controls. This suggests Chlamydia may play a role in causing this type of arthritis.
A Brazilian study found that current guidelines for sexually transmitted infections are woefully inadequate, with only 32% of infected women correctly identified using the World Health Organization's risk assessment score. The researchers recommend rapid and less costly diagnostic tests to control the spread of STIs in adolescents.
A study of over 1,000 female sex workers in Cambodia found that new entrants were twice as likely to have gonorrhoea or chlamydia. The high risk is attributed to limited access to STI services and prevention information. The study highlights the need for improved health education and training programs for sex workers.
Rates of sexually transmitted infections (STIs) have more than doubled among people aged 45 and older between 1996 and 2003. Genital warts and herpes were the most common STIs diagnosed in this age group, with rates highest among men aged 55-60 plus and women aged 45-54.
Trachoma causes blindness in 84 million people worldwide, but progress has been made since 1995 with a decline from 15% to 4% of global blindness. The SAFE strategy's success is attributed to improved socioeconomic conditions and widespread implementation.
A study found that young Australian women would accept age-based chlamydia screening, but prefer it be offered universally, rather than based on their sexual history. The researchers suggest that detailed sexual history should not be required before testing women for chlamydia to improve screening rates and reduce stigma.
A study in Ethiopia found that biannual mass azithromycin treatment significantly reduced eye infections caused by chlamydia in preschool children, from 42.6% to 0.9%, compared to annual treatment, which reduced infections by 6-fold.
Research finds that multiple species of Chlamydiae bacteria are involved in trachoma, contradicting previous assumptions. The study suggests that a one-size-fits-all approach to treatment may not be effective, highlighting the need for new vaccine and treatment strategies.
The new Chlamydia rapid test detects infection in over 4 out of 5 infected women, even without symptoms. The test can provide results in under 30 minutes and is up to twice as accurate as current tests.
Cases of lymphogranuloma venereum have surged in the UK, primarily affecting men who have sex with men, with many also infected with HIV. Experts are urging caution on new diagnostic tests that require careful validation before widespread use.
Anthony Azenabor's research reveals that Chlamydia bacteria can manipulate macrophage cell walls, causing atherosclerosis and disrupting hormone production in the placenta. This discovery could lead to new treatments for both heart disease and infertility by blocking cholesterol signaling.
A research team led by Dr. Michael Starnbach is using genetically engineered mice to study the immune system's response to Chlamydia infections. They aim to understand which components of the immune system need to be stimulated to fight the infection, with the ultimate goal of developing a vaccine for adolescent girls.
Scientists at Children's Hospital of Pittsburgh have identified a plasmid-deficient strain of Chlamydia that fails to cause disease in animal models. This finding represents a major step forward in developing a vaccine against chlamydial disease, with potential to protect against damage to reproductive organs and infertility.
A review of type 2 diabetes treatment found older agents have similar or superior effects on glycemic control and intermediate endpoints compared to newer, pricier medications. Gonorrhea is becoming resistant to fluoroquinolone antibiotics, leading to recommendations for alternative treatments.
Researchers have identified certain proteins that can protect against Chlamydia infection and are working towards developing a vaccine for adolescent women. The funding boost will allow QUT to evaluate the effectiveness of prevention methods, including a potential patch-based delivery system.
A new study led by Dr. Deborah Dean suggests that Chlamydia trachomatis is evolving rapidly through recombination, creating new strains and potentially new diseases. The bacterium's ability to customize its attack increases the risk of emerging diseases.
Scientists have discovered that the Chlamydia bacterium shares a common ancestry with plants, which could lead to the development of an effective new treatment for chlamydia. The discovery highlights similarities in genetic sequences and functions between the two organisms, providing a potential target for antibiotics.
A new study suggests that rifaximin may improve IBS symptoms by over 50% compared to placebo. However, the researchers caution that antibiotics can have side effects and more research is needed to fully understand its benefits.
Researchers found that doxycycline effectively regresses lymphoma in both positive and negative patients for Chlamydia psittaci, offering a safe alternative to chemotherapy and radiation. The study showed a 66% rate of disease-free survival among patients treated with doxycycline.
A survey of over 2500 men found that almost half who paid for sex had a current partner. Unprotected oral sex was twice as common among those who paid locally, highlighting its role in transmission of STIs.
A study in Vietnam found that targeted oral azithromycin treatment increased re-infection rates of trachoma and Chlamydia trachomatis infection. The SAFE strategy, which includes antibiotics, has been criticized for its potential ineffectiveness in long-term control.
Researchers found different types of immune response in children with varying levels of infection, including pro-inflammatory and regulatory responses. These findings may help design vaccines to prevent trachoma infection.
Researchers at Harvard Medical School have created a new mouse model that allows scientists to study how the immune system responds to Chlamydia. The breakthrough enables tracking of T cell responses in reproductive tissues, shedding light on potential avenues for developing vaccines against this common STD.
A long-term study of over 44,000 women found that Chlamydia testing increased the risk of severe reproductive complications, but at lower rates than previously thought. The study suggests that current screening programs may not be as effective as assumed, raising questions about their cost-effectiveness.
A new point-of-care assay for C trachomatis has shown higher specificity and sensitivity than the standard TF technique, allowing for more targeted treatment of trachoma. The study's findings suggest a major re-think in how trachoma control is conducted in Africa.
A recent screening conducted by student health centers revealed a 13% prevalence rate of chlamydia among college freshmen. The Centers for Disease Control and Prevention emphasize the importance of providing regular chlamydia education, screening, and testing services to all students, particularly high-risk groups.
A study found that more sensitive Chlamydia testing led to a significant increase in reported cases, with a 62% jump in female infections and a 56% rise in male infections between 1992 and 2003. The shift from culture tests to nucleic acid amplification testing (NAAT) is believed to be the primary cause of this increase.
A text messaging service reduced the average number of days to diagnosis from 11 to under 8, saving staff time and costs. The study found that a text messaging service minimizes the risks of missed results and is often more acceptable for patients with limited access to landlines.
The study found that Chlamydial infection was common in both heterosexual and homosexual men with NGU, with C. trachomatis and M. genitalium being associated with unprotected vaginal sex. Oral-genital contact may be an important mechanism of NGU pathogen transmission, according to the findings.
Researchers discover Chlamydia exploits lipid droplets for growth and replication, causing proliferation of new lipid droplets on host cells. Inhibiting lipid droplet formation impairs bacterial growth, presenting a new target for anti-Chlamydia drugs.
New data from ECCO suggests a strong correlation between Chlamydia psittaci infection and development of ocular adnexal lymphoma (OAL), with C. psittaci found in 78% of all OAL cases but only 23% of non-cancerous disease cases.
Sheila West and colleagues found that yearly mass treatment significantly reduced the prevalence of chlamydia trachomatis infection in a Tanzanian community. However, infection re-emerged after 1-year, highlighting the need for sustained antibiotic coverage.
A new study found that patient-delivered partner treatment reduces STD recurrence and transmission. The method involves giving patients antibiotics to offer to their partners, resulting in higher referral rates and reduced unprotected sex.
Researchers at Johns Hopkins found that home test kits are highly effective in detecting Chlamydia and gonorrhea among young women. The study showed that 87% of participants used the internet to order the kit, and 95% of those who tested positive for Chlamydia sought treatment.
Researchers found a strong association between high levels of C. pneumoniae antibodies and the occurrence of heart attacks in young men. The study suggests that C. pneumoniae may play a role in the pathogenesis of heart disease, but further research is needed to confirm the link.
A two-year pilot scheme to offer free Chlamydia trachomatis testing in UK pharmacies aims to combat rising infection rates. However, concerns surround adequate training for pharmacists and the provision of follow-up care for those testing positive.
A study led by Hopkins researchers found that providing packets of antibiotics or mailing medication directly to partners significantly reduced re-infections with gonorrhea and Chlamydia. The expedited approach resulted in a 68% decrease in re-infections with gonorrhea and an 18% decrease overall, when results for both diseases were co...
A study of US travelers who died from malaria between 1963 and 2001 found that most deaths were preventable with proper medication and medical care. The researchers call for better education and resources for travelers and healthcare providers to reduce malaria-related deaths.
A recent study found that high levels of perceived parental supervision were linked with reduced gonorrhea and chlamydia infections in African American female adolescents. The study, which recruited 158 adolescent females aged 14-19 years, discovered a correlation between high parental supervision and lower incidence rates of these STDs.
A new study by UNC researchers reveals a high prevalence of chlamydia in US young adults, with rates significantly higher among black men and women. The study found that the infection was present in all racial groups but was most common in the South.
A study found that the overall prevalence of chlamydial infection was 4.19% among young adults aged 18-26, with higher rates among women, black Americans, and those in the south. Gonorrhea prevalence was also significant, with co-infection rates being low.
Researchers found decreased pregnancy rates in couples where the man had IgG antibodies, a marker of previous or persistent infection by Chlamydia trachomatis. For those infertile couples with IgG antibodies, 6.8% of women and 7.1% of men carried Chlamydia DNA in their urine, suggesting active infection.
A study by Ferreri et al. found Chlamydia psittaci DNA in 80% of ocular adnexal lymphoma samples, suggesting a potential role in the disease's development. No association was found with C. trachomatis or C. pneumoniae.
A recent study found that nearly 10% of female Army recruits tested positive for chlamydia, with rates increasing over time, highlighting the need for regular screenings and treatments to prevent long-term health consequences like pelvic inflammatory disease and infertility.
A study of 800 young male army recruits found that nearly 10% could have chlamydia infection, with a higher proportion than previously reported having asymptomatic cases. Infected men were equally active sexually as the general population.
The American College of Preventive Medicine recommends widespread screening for chlamydia in high-risk populations due to its high prevalence and asymptomatic cases. Effective screening can lead to timely diagnosis and treatment, reducing the risk of pelvic inflammatory disease and other long-term complications.
A new study using powerful DNA-amplification tests found that up to 3% of participants had untreated chlamydia and over 5% had untreated gonorrhea, suggesting a large reservoir of asymptomatic infections. The high prevalence rates in the general public and lack of symptoms emphasize the importance of screening programs and extended acc...
The survey found rising numbers of heterosexual partners, concurrent relationships, and STI cases, with women experiencing more significant increases. Early age at first intercourse was linked to higher pregnancy rates and lower condom use.
Researchers identified a toxin gene in Chlamydia trachomatis that causes blindness and debilitating genital tract infections. The discovery offers new avenues for treating or preventing these diseases.
A recent study found that almost one in three young women under 25 are infected with chlamydia, compared to fewer than one in 10 older women. Regular screenings at six-month intervals can help prevent re-infections and infertility in this age group.
A study conducted in southeast London found that Black Caribbean individuals have three times the rate of gonorrhoea and eight times the rate of chlamydia as black Africans. These disparities are attributed to factors such as deprivation, cultural variations, and behavior.
Research suggests that home screening kits for Chlamydia, a common sexually transmitted infection, could be a useful tool in preventing lifelong infertility. The study found that men and women aged 18-35 were willing to participate in urine test kits, with higher participation rates among those from Avon than London.